Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

We performed a randomized controlled trial to evaluate the safety and efficacy of enoxaparin, a low-molecular-weight heparin, in preventing portal vein thrombosis (PVT) in patients with advanced cirrhosis.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Gastroenterology

Title: Gastroenterology

Publisher: Elsevier BV

ISSN (Electronic): 1528-0012

ISSN (Print): 0016-5085

Publication date (Electronic): Nov 2012

Volume: 143

Issue: 5

Affiliations

[1 ] Department of Gastroenterology, Azienda Ospedaliero-Universitaria and University of Modena and Reggio Emilia, Modena, Italy. Electronic address: erica.villa@unimore.it.

[2 ] Sezione di Gastroenterologia, Dipartimento Biomedico di Medicina Interna e Specialistica, University of Palermo, Palermo, Italy.

[3 ] Department of Haematology, Azienda Ospedaliero-Universitaria, Modena, Italy.

[4 ] Department of Gastroenterology, Azienda Ospedaliero-Universitaria and University of Modena and Reggio Emilia, Modena, Italy.

[5 ] Department of Radiology, Azienda Ospedaliero-Universitaria, Modena, Italy.

[6 ] Haematology Laboratory, Azienda Ospedaliero-Universitaria, Modena, Italy.

[7 ] Azienda Santa Maria Nuova, Reggio Emilia, Italy.

[8 ] Service d'Hépatologie, Hôpital Beaujon, APHP, Clichy, France; Université Paris-Diderot, Paris, France; INSERM U773-CRB3, Paris, France.

Article

Publisher Item ID: S0016-5085(12)01011-6

DOI: 10.1053/j.gastro.2012.07.018

PubMed ID: 22819864

SO-VID: 7fa3c3a9-3abc-4082-ae42-c60b13a4a80c

History

Data availability:

Comments

Comment on this article

scite_

Cited by 178

See all cited by

- Version 1